# Sphere Entertainment Co.: financial statements, quarterly

SPHR · NYSE · CIK 1795250 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sphr.md) · [Financials](/companies/sphr/financials.md) · [Filings](/companies/sphr/filings.md) · [Insiders](/companies/sphr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sphr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [117](/filings/0001795250-24-000042.md) | [313](/filings/0001795250-24-000009.md) | [321](/filings/0001795250-25-000029.md) | [273](/filings/0001628280-25-039390.md) | [227](/filings/0001628280-25-049008.md) | [308](/filings/0001795250-25-000011.md) | [280](/filings/0001628280-26-030740.md) | [282](/filings/0001628280-26-051125.md) | [262](/filings/0001628280-25-049008.md) | [394 d](/filings/0001628280-26-007760.md) | [386](/filings/0001628280-26-030740.md) | [313](/filings/0001628280-26-051125.md) |
| Selling, general and administrative | $m | [87.1](/filings/0001795250-24-000042.md) | [116 d](/filings/0001795250-25-000011.md) | [123](/filings/0001795250-25-000029.md) | [107](/filings/0001628280-25-039390.md) | [119](/filings/0001628280-25-049008.md) | [135 d](/filings/0001795250-25-000011.md) | [114](/filings/0001628280-26-030740.md) | [113](/filings/0001628280-26-051125.md) | [99.7](/filings/0001628280-25-049008.md) | not reported | [122](/filings/0001628280-26-030740.md) | [139](/filings/0001628280-26-051125.md) |
| Operating income | $m | [(69.8)](/filings/0001795250-25-000011.md) | [(160)](/filings/0001795250-25-000011.md) | [(40.4)](/filings/0001795250-25-000029.md) | [(71.4)](/filings/0001628280-25-039390.md) | [(118)](/filings/0001628280-25-049008.md) | [(143)](/filings/0001795250-25-000011.md) | [(78.6)](/filings/0001628280-26-030740.md) | [(50.2)](/filings/0001628280-26-051125.md) | [(130)](/filings/0001628280-25-049008.md) | [28.9 d](/filings/0001628280-26-007760.md) | [7.2](/filings/0001628280-26-030740.md) | [(61.3)](/filings/0001628280-26-051125.md) |
| Interest expense | $m | [0.0](/filings/0001795250-24-000042.md) | [25.8 d](/filings/0001795250-25-000011.md) | [27.1](/filings/0001795250-25-000029.md) | [26.9](/filings/0001628280-25-039390.md) | [27.0](/filings/0001628280-25-049008.md) | [30.4 d](/filings/0001795250-25-000011.md) | [26.2](/filings/0001628280-26-030740.md) | [25.9](/filings/0001628280-26-051125.md) | [9.4](/filings/0001628280-25-049008.md) | not reported | [8.0](/filings/0001628280-26-030740.md) | [8.3](/filings/0001628280-26-051125.md) |
| Income tax | $m | [(90.3)](/filings/0001795250-24-000042.md) | [(7.5) d](/filings/0001795250-25-000011.md) | [(15.9)](/filings/0001795250-25-000029.md) | [(22.0)](/filings/0001628280-25-039390.md) | [(33.0)](/filings/0001628280-25-049008.md) | [(42.4) d](/filings/0001628280-26-007760.md) | [(20.3)](/filings/0001628280-26-030740.md) | [122](/filings/0001628280-26-051125.md) | [(35.5)](/filings/0001628280-25-049008.md) | [(42.3) d](/filings/0001628280-26-007760.md) | [(4.8)](/filings/0001628280-26-030740.md) | [(26.9)](/filings/0001628280-26-051125.md) |
| Net income | $m | [66.4](/filings/0001795250-25-000011.md) | [(173)](/filings/0001795250-25-000011.md) | [(47.2)](/filings/0001628280-25-049008.md) | [(46.6)](/filings/0001628280-25-049008.md) | [(105)](/filings/0001628280-25-049008.md) | [(126)](/filings/0001795250-25-000011.md) | [(82.0)](/filings/0001628280-26-051125.md) | [152](/filings/0001628280-26-051125.md) | [(101)](/filings/0001628280-25-049008.md) | [64.7 d](/filings/0001628280-26-007760.md) | [4.5](/filings/0001628280-26-051125.md) | [(38.3)](/filings/0001628280-26-051125.md) |
| Diluted EPS | $ per share | [1.89](/filings/0001795250-24-000042.md) | [(4.91)](/filings/0001795250-24-000009.md) | [(1.33)](/filings/0001795250-25-000029.md) | [(1.31)](/filings/0001628280-25-039390.md) | [(2.95)](/filings/0001628280-25-049008.md) | not reported | [(2.27)](/filings/0001628280-26-030740.md) | [3.39](/filings/0001628280-26-051125.md) | [(2.80)](/filings/0001628280-25-049008.md) | not reported | [(0.04)](/filings/0001628280-26-030740.md) | [(1.07)](/filings/0001628280-26-051125.md) |
| Basic EPS | $ per share | [1.90](/filings/0001795250-24-000042.md) | [(4.91)](/filings/0001795250-24-000009.md) | [(1.33)](/filings/0001795250-25-000029.md) | [(1.31)](/filings/0001628280-25-039390.md) | [(2.95)](/filings/0001628280-25-049008.md) | not reported | [(2.27)](/filings/0001628280-26-030740.md) | [4.18](/filings/0001628280-26-051125.md) | [(2.80)](/filings/0001628280-25-049008.md) | not reported | [(0.04)](/filings/0001628280-26-030740.md) | [(1.07)](/filings/0001628280-26-051125.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [434](/filings/0001795250-24-000009.md) | [615](/filings/0001795250-24-000009.md) | not reported | [560](/filings/0001795250-24-000042.md) | [540](/filings/0001795250-25-000011.md) | [502](/filings/0001628280-25-049008.md) | [465](/filings/0001795250-25-000029.md) | [356](/filings/0001628280-25-039390.md) | [385](/filings/0001628280-25-049008.md) | [508](/filings/0001628280-26-051125.md) | [629](/filings/0001628280-26-030740.md) | [551](/filings/0001628280-26-051125.md) |
| Current assets | $m | [674](/filings/0001795250-23-000023.md) | [879](/filings/0001795250-24-000009.md) | [916](/filings/0001795250-24-000018.md) | [866](/filings/0001795250-25-000011.md) | [736](/filings/0001795250-24-000042.md) | [761](/filings/0001628280-26-007760.md) | [735](/filings/0001795250-25-000029.md) | [595](/filings/0001628280-25-039390.md) | [666](/filings/0001628280-25-049008.md) | [810](/filings/0001628280-26-051125.md) | [904](/filings/0001628280-26-030740.md) | [784](/filings/0001628280-26-051125.md) |
| Total assets | $m | [4,865](/filings/0001795250-23-000023.md) | [4,883](/filings/0001795250-24-000009.md) | [4,869](/filings/0001795250-24-000018.md) | [4,788](/filings/0001795250-25-000011.md) | [4,593](/filings/0001795250-24-000042.md) | [4,515](/filings/0001628280-26-007760.md) | [4,448](/filings/0001795250-25-000029.md) | [4,199](/filings/0001628280-25-039390.md) | [4,139](/filings/0001628280-25-049008.md) | [4,210](/filings/0001628280-26-051125.md) | [4,223](/filings/0001628280-26-030740.md) | [4,036](/filings/0001628280-26-051125.md) |
| Current liabilities | $m | [643](/filings/0001795250-23-000023.md) | [1,399](/filings/0001795250-24-000009.md) | [1,399](/filings/0001795250-24-000018.md) | [1,374](/filings/0001795250-25-000011.md) | [1,315](/filings/0001795250-24-000042.md) | [1,372](/filings/0001628280-26-007760.md) | [1,381](/filings/0001795250-25-000029.md) | [527](/filings/0001628280-25-039390.md) | [697](/filings/0001628280-25-049008.md) | [743](/filings/0001628280-26-051125.md) | [743](/filings/0001628280-26-030740.md) | [640](/filings/0001628280-26-051125.md) |
| Total liabilities | $m | [2,229](/filings/0001795250-23-000023.md) | [2,418](/filings/0001795250-24-000009.md) | [2,425](/filings/0001795250-24-000018.md) | [2,372](/filings/0001795250-25-000011.md) | [2,278](/filings/0001795250-24-000042.md) | [2,314](/filings/0001628280-26-007760.md) | [2,306](/filings/0001795250-25-000029.md) | [1,885](/filings/0001628280-25-039390.md) | [1,983](/filings/0001628280-25-049008.md) | [1,977](/filings/0001628280-26-051125.md) | [1,975](/filings/0001628280-26-030740.md) | [1,808](/filings/0001628280-26-051125.md) |
| Long-term debt | $m | [1,098](/filings/0001795250-23-000023.md) | [521](/filings/0001795250-24-000009.md) | [522](/filings/0001795250-24-000018.md) | [523](/filings/0001795250-25-000011.md) | [523](/filings/0001795250-24-000042.md) | [524](/filings/0001628280-26-007760.md) | [525](/filings/0001795250-25-000029.md) | [831](/filings/0001628280-25-039390.md) | [786](/filings/0001628280-25-049008.md) | [767](/filings/0001628280-26-051125.md) | [753](/filings/0001628280-26-030740.md) | [722](/filings/0001628280-26-051125.md) |
| Current portion of debt | $m | [103](/filings/0001795250-23-000023.md) | [890](/filings/0001795250-24-000009.md) | [870](/filings/0001795250-24-000018.md) | [849](/filings/0001795250-25-000011.md) | [829](/filings/0001795250-24-000042.md) | [829](/filings/0001628280-26-007760.md) | [804](/filings/0001795250-25-000029.md) | [58.8](/filings/0001628280-25-039390.md) | [88.8](/filings/0001628280-25-049008.md) | [63.0](/filings/0001628280-26-051125.md) | [57.7](/filings/0001628280-26-030740.md) | [58.3](/filings/0001628280-26-051125.md) |
| Shareholders' equity | $m | [2,636](/filings/0001795250-23-000023.md) | [2,465](/filings/0001628280-25-049008.md) | [2,444](/filings/0001628280-25-049008.md) | [2,416](/filings/0001628280-26-007760.md) | [2,314](/filings/0001628280-25-049008.md) | [2,201](/filings/0001628280-26-051125.md) | [2,142](/filings/0001628280-26-051125.md) | [2,314](/filings/0001628280-26-051125.md) | [2,155](/filings/0001628280-25-049008.md) | [2,233](/filings/0001628280-26-051125.md) | [2,248](/filings/0001628280-26-051125.md) | [2,228](/filings/0001628280-26-051125.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(94.6)](/filings/0001795250-24-000042.md) | [46.4 d](/filings/0001795250-24-000009.md) | [101](/filings/0001795250-25-000029.md) | [(72.4) d](/filings/0001628280-26-007760.md) | [34.1](/filings/0001795250-24-000042.md) | [6.7 d](/filings/0001628280-26-007760.md) | [6.3](/filings/0001628280-26-030740.md) | [(59.1) d](/filings/0001628280-26-051125.md) | [116 d](/filings/0001628280-25-049008.md) | [180 d](/filings/0001628280-26-007760.md) | [136](/filings/0001628280-26-030740.md) | [(33.7) d](/filings/0001628280-26-051125.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0) d](/filings/0001628280-26-007760.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.7](/filings/0001795250-24-000009.md) | [34.7](/filings/0001795250-24-000018.md) | [35.2](/filings/0001795250-24-000042.md) | [35.3](/filings/0001795250-24-000009.md) | [35.4](/filings/0001795250-25-000029.md) | [35.6](/filings/0001628280-25-039390.md) | [35.7](/filings/0001628280-25-049008.md) | [36.1](/filings/0001628280-26-030740.md) | [44.8](/filings/0001628280-26-051125.md) | [36.2](/filings/0001628280-25-049008.md) | [35.9](/filings/0001628280-26-030740.md) | [36.2](/filings/0001628280-26-051125.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.